HomeInsightsResults

Tatva Chintan Pharma Chem Ltd Quarterly Result

Tatva Chintan Pharma Chem Ltd Quarterly Result

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

2.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

Net Profit

₹ -0.66

Last updated on: Nov 24, 2024

Key Highlights

  • The revenue of Tatva Chintan Pharma Chem Ltd for the Sep '24 is ₹ 83.87 crore as compare to the Jun '24 revenue of ₹ 106.64 crore. This represent the decline of -21.352211%.
  • The ebitda of Tatva Chintan Pharma Chem Ltd for the Sep '24 is ₹ 5.96 crore as compare to the Jun '24 ebitda of ₹ 13.79 crore. This represent the decline of -56.780277%.
  • The net profit of Tatva Chintan Pharma Chem Ltd for the Sep '24 is ₹ -0.66 crore as compare to the Jun '24 net profit of ₹ 5.21 crore. This represent the decline of -112%.

Results Analysis

Market Price of Tatva Chintan Pharma Chem Ltd

1M

1Y

3Y

5Y

Monitoring Tatva Chintan Pharma Chem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024823
21 Nov 2024807.25
19 Nov 2024829.65
18 Nov 2024829.4
14 Nov 2024832.75
13 Nov 2024840.45
12 Nov 2024881.5
11 Nov 2024876.4
08 Nov 2024905.35
07 Nov 2024908.3

Historical Revenue of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical EBITDA of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical Net Profit of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Tatva Chintan Pharma Chem Ltd News Hub

News

Tatva Chintan Pharma Chem to discuss results

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 202416:28

News

Tatva Chintan Pharma Chem AGM scheduled

Tatva Chintan Pharma Chem announced that the Annual General Meeting (AGM) of the company w...

Read more

28 Aug 202414:54

News

Tatva Chintan Pharma Chem to convene board meeting

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

16 Jul 202415:55

News

Tatva Chintan Pharma Q4 PAT drops 43% YoY to Rs 96 cr

Revenue from operations fell 21.08% YoY to Rs 98.26 crore in Q4 FY24. During the quarter, ...

Read more

04 May 202413:28

News

Board of Tatva Chintan Pharma Chem recommends final dividend

Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meet...

Read more

03 May 202416:15

News

Tatva Chintan Pharma Chem to convene board meeting

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

25 Apr 202410:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Tatva Chintan Pharma Chem Ltd Quarterly Result

What is the EPS of Tatva Chintan Pharma Chem Ltd stock?

The Earnings Per Share (EPS) of Tatva Chintan Pharma Chem Ltd is 7.53. An EPS is the amount of net income attributed to each share of a common stock.

How is Tatva Chintan Pharma Chem Ltd EPS calculated?

The EPS of Tatva Chintan Pharma Chem Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Tatva Chintan Pharma Chem Ltd report its EPS?

Tatva Chintan Pharma Chem Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Tatva Chintan Pharma Chem Ltd EPS?

Factors that influence the EPS of Tatva Chintan Pharma Chem Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Tatva Chintan Pharma Chem Ltd EPS growth indicate future performance?

Yes, consistent growth in Tatva Chintan Pharma Chem Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*